Lazard Asset Management LLC lifted its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD – Get Rating) by 63.7% in the second quarter, Holdings Channel reports. The firm owned 1,370 shares of the medical instruments supplier’s stock after buying an additional 533 shares during the period. Lazard Asset Management LLC’s holdings in Utah Medical Products were worth $117,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in UTMD. Isthmus Partners LLC boosted its position in shares of Utah Medical Products by 6.1% in the 1st quarter. Isthmus Partners LLC now owns 18,605 shares of the medical instruments supplier’s stock worth $1,672,000 after purchasing an additional 1,071 shares in the last quarter. Russell Investments Group Ltd. raised its stake in Utah Medical Products by 4.0% in the 1st quarter. Russell Investments Group Ltd. now owns 81,658 shares of the medical instruments supplier’s stock worth $7,336,000 after acquiring an additional 3,160 shares during the last quarter. HealthInvest Partners AB raised its stake in Utah Medical Products by 40.0% in the 1st quarter. HealthInvest Partners AB now owns 56,000 shares of the medical instruments supplier’s stock worth $5,032,000 after acquiring an additional 16,000 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Utah Medical Products by 16.9% in the 1st quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical instruments supplier’s stock worth $9,145,000 after acquiring an additional 14,693 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in Utah Medical Products by 2.0% in the 1st quarter. Bank of New York Mellon Corp now owns 19,948 shares of the medical instruments supplier’s stock worth $1,793,000 after acquiring an additional 389 shares during the last quarter. Institutional investors and hedge funds own 61.51% of the company’s stock.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on Utah Medical Products in a research note on Wednesday, October 12th. They issued a “strong-buy” rating for the company.
Utah Medical Products Price Performance
Utah Medical Products Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 4th. Investors of record on Friday, December 16th will be paid a $0.295 dividend. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.29. The ex-dividend date of this dividend is Thursday, December 15th. This represents a $1.18 dividend on an annualized basis and a yield of 1.27%. Utah Medical Products’s dividend payout ratio (DPR) is 26.42%.
About Utah Medical Products
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
- Get a free copy of the StockNews.com research report on Utah Medical Products (UTMD)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
- Want to Get a 10% Dividend Yield, Look Here
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.